Spyre Therapeutics (SYRE) Return on Assets (2016 - 2026)

Spyre Therapeutics (SYRE) has 11 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2026 and bottomed at 0.02% in Q2 2023.
• The 5-year median for Return on Assets is 0.01% (2022), against an average of 0.01%.
• The widest annual swing landed in 2023, when Return on Assets slipped 1 bps; it then gained 1 bps in 2024.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then slipped by 20 bps to 0.01% in 2023, then jumped by 67 bps to 0.0% in 2024, then soared by 40 bps to 0.0% in 2025, then gained by 4 bps to 0.0% in 2026.
• The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison